JOHN BALMER: Open Payments
NPI 1104912476 · SPARTANSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,917 in 117 payments from 22 companies in 2025. Trend: 2023 $2,429 · 2024 $2,441 · 2025 $2,917
Food & beverage: $2,917
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $447 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $346 |
| AstraZeneca Pharmaceuticals LP | 7 | $318 |
| ABBVIE INC. | 18 | $311 |
| Amgen Inc. | 10 | $279 |
| Madrigal Pharmaceuticals | 5 | $165 |
| PFIZER INC. | 12 | $160 |
| Axsome Therapeutics, Inc. | 8 | $135 |
| Grifols USA, LLC | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 3 | $98 |
Products named: CAPLYTA, Ozempic, BREZTRI, REZDIFFRA, VRAYLAR, REPATHA, Auvelity, Prolastin-C Liquid.
Industry payments across PA — which companies pay providers there.
